Skip to main content

Understand what a genetic change MEANS

See How It Works
Built for genomic research teams
NVIDIA Inception ProgramAWS
Trusted by leading research teams

For research use only. Not intended for diagnosis, treatment, or clinical decision-making.

See GeneGenius in action

Watch how GeneGenius turns complex DNA data into clear, evidence-backed insights and a research-ready report.

The Rare Disease Bottleneck

Why this matters now

Rare disease diagnosis can take years, while the cost of delayed answers continues to rise. At the same time, genomic data is growing faster than specialist teams can interpret it. The annual U.S. economic burden of rare disease is estimated to approach$1 trillion.

25–30M
Americans living with a rare disease
Source: NIH GARD FAQ (2024)
5+ years
Average time to diagnosis
Source: NORD Rare Disease Facts (2024)
$517K
Estimated avoidable cost per patient associated with delayed diagnosis
Source: EveryLife Delayed Diagnosis Study (2023)
Organizational Value

More genomic capacity. More services. Better economics.

GeneGenius helps laboratories and research programs complete more genomic work with existing teams, retain more analysis in-house, and expand the services they can offer.

Capacity

Increase throughput

Complete more genomic analyses without increasing specialist headcount at the same rate.

Retention

Retain more value

Reduce dependence on outsourced interpretation and keep more genomic work within the organization.

Revenue

Expand services

Support reanalysis, cohort research, evidence reporting, and new genomic research programs.

For hospitals and academic medical centers, this can also support larger research cohorts, biobank programs, sponsored studies, and pharmaceutical partnerships.